ZZW-115 is primarily recognized for its potential in cancer research, particularly in targeting and inhibiting specific pathways involved in tumor growth. It has shown promise in preclinical studies as a selective inhibitor of certain proteins that play a critical role in cancer cell survival and proliferation. Researchers are exploring its application in treating various cancers, including those resistant to conventional therapies. Additionally, ZZW-115 is being studied for its ability to enhance the efficacy of existing chemotherapy drugs, potentially reducing required dosages and minimizing side effects. Its role in inducing cancer cell death while sparing healthy cells makes it a candidate for developing more targeted and less toxic cancer treatments.